Globally the social, demographic and economic context in which the pharmaceutical industry operates is changing dramatically. These changes will generate some huge opportunities for Pharma over the next decade. But the current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. In order to make the most of these future growth opportunities, the industry must fundamentally change the way it operates. Most big Pharma companies have traditionally done everything from research and development (R&D) through to commercialisation themselves. But we predict that, by 2020, this model will no longer work for many organisations. If they are to prosper, they will need to improve their R&D productivity, reduce their costs, tap the potential of the emerging economies and switch from Selling medicines to managing outcomes – activities few, if any, companies can accomplish on their own. Even the largest pharmaceutical companies will soon need to step outside their sector and collaborate with other organizations. As a result of which, the pharmaceutical industry all over the world is undergoing increasing amount of concentration, which coincides with the occurrence of a large number of consolidation strategies such as mergers, acquisitions, alliances and partnerships.

Focus of this year’s Pharma Summit 2011 is to explore how the industry is collaborating and consolidating for growth and discuss strategies and challenges ahead. It will also focus on charting a road map for companies operating in the Indian market, to suitably adapt their business models and capitalize on India’s growing potential and convert them into success stories.

In line with the program theme, this thought provoking interactive roundtable session aims at bringing together the eminent thought leaders who are leading players in the Indian Pharmaceutical Industry on a common platform. Each of the panelists would share their views on critical areas of concern and challenges that need to be addressed at the stage of execution by Indian and foreign pharma companies as they continue to expand operations through alliances and partnerships in domestic market.

The Roundtable will also attempt to enable the Pharma Industry to crystallize the path ahead for its players in the domestic arena and identify sustainable business model for maximising growth.

This session will endeavour to live up to its theme of "India Pharma Inc. – Enhancing Value through Alliances and Partnerships"

Partnerships and alliances are becoming the most favoured method of operation for pharmaceutical companies looking to expand their geographic footprint and boost their capabilities and products basket. Longer-term strategic alliances between two or more interested parties can bring high levels of collaboration, enhanced responsiveness and improved efficiency and productivity for both parties.This plenary will focus on understanding the emerging business model of alliances and partnerships, trends & Challenges with keeping in mind the quality & cost as an important area and will also highlight the growing importance of newer markets like Japan for partnerships.